VNDA On Watch, NUVA Q2 Results Miss Estimates, MRTX Awaits FDA Decision...
WASHINGTON (dpa-AFX) - The following are some of the healthcare companies that reported quarterly financial results and provided a pipeline update on Wednesday.1. Vanda To Report Bipolar Disorder
Source: finanznachrichten.de